These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 82488)

  • 1. Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections.
    Bell RB; Aurelian L; Cohen GH
    Cell Immunol; 1978 Nov; 41(1):86-102. PubMed ID: 82488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunohistochemical study of condyloma and and carcinoembryonic antigens in the uterine cervix in human papilloma virus infection and neoplasia].
    Alcántara-Vázquez A; Rodríguez-Martínez HA; Gómez-Ramírez AM; Cruz-Ortiz H; Orozco-Estéves H
    Rev Invest Clin; 1985; 37(4):291-6. PubMed ID: 3006200
    [No Abstract]   [Full Text] [Related]  

  • 3. [Human papillomavirus infection and carcinogenesis of cancer of uterine cervix. II. Immunoperoxidase localization of papilloma-virus antigen in tissues of the uterine cervix].
    Shu LL; Yang XZ
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):430-2, 23. PubMed ID: 2838240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-epidemiology of herpes type-2 virus and carcinoma of the cervix in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1977 Jun; 6(2):95-102. PubMed ID: 416672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A, B & H isoantigens in cervical lesions.
    Bisht D; Misra V; Gupta SC; Mehrotra R; Garg S
    Indian J Pathol Microbiol; 1998 Jan; 41(1):11-4. PubMed ID: 9581070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
    Aurelian L; Strandberg JD; Marcus RL
    Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 9. Demonstration of tumor associated antigen in squamous cell carcinoma of cervix by immunodiffusion.
    Tsai WS; Chiang WT; Wei PY; Alexander ER
    Taiwan Yi Xue Hui Za Zhi; 1976 Sep; 75(9):489-96. PubMed ID: 827599
    [No Abstract]   [Full Text] [Related]  

  • 10. The antigenicity and immunology of human cervical squamous cell carcinoma: a review.
    McCoy JP; Haines HG
    Am J Obstet Gynecol; 1981 Jun; 140(3):329-36. PubMed ID: 7018244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic deletion in cervical neoplasia.
    Ashley C; Kirkland JA; Stanley MA
    Pathology; 1974 Oct; 6(4):329-35. PubMed ID: 4615290
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.
    Chiang WT; Wei PY; Alexander ER
    Am J Obstet Gynecol; 1976 Sep; 126(1):116-21. PubMed ID: 786019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 15. Herpesvirus hominis: from latency to carcinogenesis?
    Aurelian L
    Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular immunity as a host response to squamous carcinoma of the cervix.
    Goldstein MS; Shore B; Gusberg SB
    Am J Obstet Gynecol; 1971 Nov; 111(6):751-5. PubMed ID: 5166388
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. 3. Houston, Texas.
    Adam E; Kaufman RH; Melnick JL; Levy AH; Rawls WE
    Am J Epidemiol; 1972 Dec; 96(6):427-42. PubMed ID: 4345340
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nonspecific immunoreactivity in women with dysplasia and cancer of the uterine cervix].
    Tosner J; Havel V; Turková M; Fixa B; Zaydlar K
    Cesk Gynekol; 1984 Jun; 49(5):338-43. PubMed ID: 6467397
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpesvirus type 2 and cervical carcinoma.
    Melnick JL; Rawls WE
    Ann N Y Acad Sci; 1970 Oct; 174(2):993-8. PubMed ID: 4322798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.